Bellus Health reduces workforce by 45%
According to Bellus Health, the current programs related to the company’s existing product and product candidates will not be affected by the cuts, which are being made primarily
Health innovation platform developer Aditxt and its fully owned subsidiary Ignite Proteomics have announced their plans for a business combination with a strategic partner that values the latter at an implied equity value of nearly $150m.